Bioasis Technologies Inc BIOAF:OTCQB

RT Quote | Exchange | USD
Last | 08/10/22 EDT
0.12UNCH (UNCH)
Volume
1,460
52 week range
0.10 - 0.28
Loading...
  • Open0.12
  • Day High0.12
  • Day Low0.12
  • Prev Close0.12
  • 52 Week High0.28
  • 52 Week High Date10/11/21
  • 52 Week Low0.10
  • 52 Week Low Date08/03/22

Key Stats

  • Market Cap7.33M
  • Shares Out72.91M
  • 10 Day Average Volume19,788.44
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-43.45

KEY STATS

  • Open0.12
  • Day High0.12
  • Day Low0.12
  • Prev Close0.12
  • 52 Week High0.28
  • 52 Week High Date10/11/21
  • 52 Week Low0.10
  • 52 Week Low Date08/03/22
  • Market Cap7.33M
  • Shares Out72.91M
  • 10 Day Average Volume19,788.44
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-43.45

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date10/31/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bioasis Technologies Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bioasis Technologies Inc. is a Canada-based development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The Company is engaged in the development of the xB3 platform, a technology for the delivery of therapeutics across the blood brain barrier (BBB) and the treatment of central nervous system (CNS) disorders in areas of high unmet medical need, including brain cancers...
Deborah Rathjen Ph.D.
Executive Chairman of the Board, President, Chief Executive Officer
Christine Antalik
Chief Financial Officer
Address
4170 Still Creek Drive, Suite 200
Burnaby, BC
V5C 6C6
Canada